TrialArteriosclerosis, thrombosis, and vascular biology2008

Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome.

Dick C Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.